EMPA-REG Outcome: results that question

被引：0
|
作者：
Pouchain, Denis [1 ]
机构：
[1] UFR Tours, Dept Univ Med Gen, Tours, France
来源：
EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE | 2016年 / 27卷 / 128期
关键词：
Empagliflozin; Hypoglycemic agents; Randomized controlled trials;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：278 / 282
页数：5
相关论文
共 50 条
  • [21] Following the results of the EMPA-REG OUTCOME trial with empagliflozin, is it possible to speak of a class effect?
    Ampudia-Blasco, Francisco Javier
    Romera, Irene
    Arino, Bernat
    Gomis, Ramon
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2017, 10 : 23 - 26
  • [22] EFFECT OF EMPAGLIFLOZIN ON CARDIOVASCULAR DEATH IN SUBGROUPS BYAGE: RESULTS FROM EMPA-REG OUTCOME
    D'Emden, M.
    Fitchett, D.
    Kis, Giljanovic S.
    Woerle, H.
    Zinman, B.
    Inzucchi, S.
    NEPHROLOGY, 2016, 21 : 58 - 58
  • [23] EMPA-REG OUTCOME: cardiovascular outcome trials in diabetes come of age
    Krentz, Andrew J.
    CARDIOVASCULAR ENDOCRINOLOGY, 2015, 4 (04): : 115 - 116
  • [24] Empa's New Clothes: The Untold Story of the Empa-Reg Outcome Trial
    Alzaid, Aus
    DIABETES TECHNOLOGY & THERAPEUTICS, 2017, 19 (06) : 324 - 327
  • [25] EMPA-REG - the "diuretic hypothesis"
    McMurray, John
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2016, 30 (01) : 3 - 4
  • [26] Effect of Empagliflozin on Cardiovascular Death in Subgroups by Age: Results from EMPA-REG Outcome
    Ridderstrale, Martin
    Toural, Elvira
    Fitchett, David
    Kis, Sanja Giljanovic
    Woerle, Hans J.
    Mattheus, Michaela
    Zinman, Bernard
    Inzucchi, Silvio E.
    DIABETES, 2016, 65 : A289 - A290
  • [27] Effect of empagliflozin on cardiovascular death in subgroups by age: results from EMPA-REG OUTCOME
    Toural, E.
    Ridderstrale, M.
    Fitchett, D.
    Kis, S. Giljanovic
    Woerle, H. -J.
    Mattheus, M.
    Zinman, B.
    Inzucchi, S. E.
    DIABETOLOGIA, 2016, 59 : S539 - S540
  • [28] Effect of empagliflozin on cardiovascular death in subgroups by age: results from EMPA-REG OUTCOME
    Ridderstrale, M.
    Fitchett, D.
    Kis, S. Giljanovic
    Woerle, H. J.
    Mattheus, M.
    Zinman, B.
    Inzucchi, S.
    EUROPEAN HEART JOURNAL, 2016, 37 : 1192 - 1192
  • [29] Improvements in Liver Enzymes with Empagliflozin in the EMPA-REG OUTCOME Trial
    Sattar, Naveed
    Fitchett, David H.
    Hantel, Stefan
    George, Jyothis T.
    Zinman, Bernard
    DIABETES, 2018, 67
  • [30] Series: Cardiovascular outcome trials for diabetes drugs Empagliflozin and EMPA-REG OUTCOME
    Fisher, Miles
    BRITISH JOURNAL OF DIABETES, 2020, 20 (02): : 138 - 141
12345